Abstract
The susceptibilities of 20 clinical isolates of Mycobacterium intracellulare to rifampin, MDL 473, and ansamycin were determined by broth and agar dilution methods. Ansamycin was more active than MDL 473, which in turn was usually more active than rifampin by either method. The MICs for 90% of the strains tested by agar dilution were 1, 2, and 4 micrograms of ansamycin, MDL 473, and rifampin per ml, respectively.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rifamycins;Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases;2010
2. Antimycobacterial Agents;Burger's Medicinal Chemistry and Drug Discovery;2003-01-15
3. In Vitro and In Vivo Activities of Gatifloxacin against
Mycobacterium tuberculosis;Antimicrobial Agents and Chemotherapy;2002-04
4. Treatment of mycobacterial infections;Revue Scientifique et Technique de l'OIE;2001-04-01
5. Evaluation of Rifalazil in a Combination Treatment Regimen as an Alternative to Isoniazid-Rifampin Therapy in a Mouse Tuberculosis Model;Antimicrobial Agents and Chemotherapy;2000-11